News
Hosted on MSN25d
US FDA approves syringe version of Argenx's immune disorder drugArgenx said the Vyvgart Hytrulo prefilled syringe will be available within the next two weeks and that it would have a comparable price to the subcutaneous vial. "The new version is going to make ...
Already thriving with a successful launch of infused Vyvgart and its subcutaneous follow-on Vyvgart ... has signed off on argenx’s prefilled syringe (PFS) version of Vyvgart Hytrulo, which ...
Vyvgart Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. The single-dose ...
The prefilled syringe will be available as a 20-to-30-second subcutaneous injection by a patient or caregiver after appropriate training or by a healthcare professional. The approval is supported ...
2mon
GlobalData on MSNEMA approves Takeda’s Takhzyro pre-filled pen option for HAEIt marks an expansion in the company’s portfolio for subcutaneous administration methods. Takhzyro has secured approval for ...
VYVGART ® Hytrulo prefilled syringe for self-injection is approved as a 20-to-30-second subcutaneous injection administered by a patient, caregiver, or healthcare professional. Patients are able ...
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results